Screenshot 2019-03-21 10.41.56.png

Empiriko is a biotech company focused on developing R&D technologies for drug discovery and point-of-care devices for personalized patient treatment.

Empiriko’s proprietary Biomimiks™ in-vitro technology closely mirrors the in-vivo metabolism of liver enzymes (cytochrome P450), mimicking the structure and function of liver enzymes to predict metabolism patterns and profiles in humans.


This technology assesses the liver’s metabolic reaction to drugs, food, and environmental agents.